Még nem toboroz
Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer
NCT07821606· 3. fázis· Hansoh BioMedical R&D Company· Forrás
Contact: Ding Ma, PhD
Még nem toboroz
Reduced-Dose Thrombolysis in Intermediate-Risk Pulmonary Embolism With High-Risk Features
NCT07917078· 3. fázis· China National Center for Cardiovascular Diseases· Forrás
Contact: Le Kang, Prof.
Még nem toboroz
Early Lumbar Drainage for Intraventricular Hemorrhage
NCT07625449· Second Affiliated Hospital of Nanchang University· Forrás
Contact: Linyi People's Hospital
Toboroz
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
NCT07732309· 1. fázis· Antengene Biologics Limited· Forrás
Contact: Peng Yan
Toboroz
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
NCT07796516· 2. fázis· Peking University People's Hospital· Forrás
Contact: Zhenchun Zhang
Toboroz
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
NCT07567625· Harbin Medical University· Forrás
Contact: Yanjin Wei
Toboroz
A Study of TAK-755 in Adults With Acute Ischemic Stroke
NCT07392450· 2. fázis· Takeda· Forrás
Contact: Ziran Wang (principal investigator)
Toboroz
Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation
NCT07444372· Beijing Anzhen Hospital· Forrás
Contact: Li Wei, Professor
Toboroz
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.
NCT07385703· 3. fázis· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Forrás
Contact: Zhongming Zhang, Master
Toboroz
Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment in Patients With Acute Ischemic Stroke
NCT07423975· 2. fázis· Beijing Tiantan Hospital· Forrás
Contact: Hao Wang, MD
Még nem toboroz
A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs
NCT07483684· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Forrás
Contact: Jinling Zhang, Master
Toboroz
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.
NCT07520565· 3. fázis· Biocells (Beijing) Biotech Co.,Ltd· Forrás
Contact: Ziran Wang
Toboroz
JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.
NCT07284134· 3. fázis· Shanghai Junshi Bioscience Co., Ltd.· Forrás
Contact: Zhongmin Zhang, Doctor
Toboroz
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
NCT07263308· 3. fázis· Capital Medical University· Forrás
Contact: Hao Wang
Fut, nem toboroz
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2
NCT07263776· 3. fázis· Capital Medical University· Forrás
Toboroz
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
NCT07282353· 3. fázis· Cascade Pharmaceuticals, Inc· Forrás
Contact: Gao Feng
Toboroz
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
NCT07279493· 2. fázis· Kunming Pharmaceuticals, Inc.· Forrás
Contact: Duo Gao, bachelor
Toboroz
Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage
NCT07208097· Tongji Hospital· Forrás
Contact: Xie Zhongxiang
Toboroz
Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy
NCT07581210· 2. fázis· Shanghai QuietD Biotechnology Co., Ltd.· Forrás
Contact: Ziran Wang
Toboroz
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2
NCT07139314· Capital Medical University· Forrás
Contact: Xianjun Wang
Fut, nem toboroz
Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
NCT07139301· Capital Medical University· Forrás
Toboroz
A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC
NCT06962865· 2. fázis· RemeGen Co., Ltd.· Forrás
Contact: Guixiang Weng
Toboroz
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
NCT07010263· 3. fázis· Akeso· Forrás
Contact: Zhongmin Zhang, M.D.
Még nem toboroz
Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer
NCT07007286· Peking University First Hospital· Forrás
Contact: Feng Gao
Toboroz
Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1 G/GEJ Adenocarcinoma
NCT06932068· 2. fázis· Qilu Hospital of Shandong University· Forrás
Contact: Jinling Zhang
Fut, nem toboroz
A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer
NCT07005336· 2. fázis· TJ Biopharma Co., Ltd.· Forrás
Toboroz
Minimally Invasive Soft Channel Brain Haemorrhage Evacuation for Acute Basal Ganglia Haemorrhage-- Large Hemorrhage Evacuation (MIRACLE-L)
NCT06688201· Capital Medical University· Forrás
Contact: XunMing Ji, PhD
Fut, nem toboroz
A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT06707883· 2. fázis· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Forrás
Toboroz
Study on Hibernation-like Therapy Based on Mechanical Thrombectomy
NCT06663631· 1. fázis· Capital Medical University· Forrás
Contact: Qi Wang, Dr.
Még nem toboroz
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).
NCT06606509· Nanjing First Hospital, Nanjing Medical University· Forrás
Contact: Qingyu Dong, Doctor
Toboroz
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
NCT06662071· Qilu Hospital of Shandong University· Forrás
Contact: Zhiqiang Shao
Fut, nem toboroz
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06564142· 3. fázis· Alpine Immune Sciences Inc, A Subsidiary of Vertex· Forrás
Fut, nem toboroz
A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma (G-HOPE-001)
NCT06238843· 3. fázis· Innovent Biologics (Suzhou) Co. Ltd.· Forrás
Toboroz
Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
NCT07169656· The First Affiliated Hospital of Zhengzhou University· Forrás
Contact: Feng Gao
Toboroz
A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
NCT06361888· 2/3. fázis· Hutchmed· Forrás
Contact: Zhongmin Zhang
Fut, nem toboroz
A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer
NCT06984588· 2/3. fázis· TJ Biopharma Co., Ltd.· Forrás
Toboroz
A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema
NCT06152107· Shanghai Chest Hospital· Forrás
Contact: Li Wei
Toboroz
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
NCT06079983· 3. fázis· Jiangsu Alphamab Biopharmaceuticals Co., Ltd· Forrás
Contact: Guixiang Weng
Fut, nem toboroz
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
NCT05899608· 3. fázis· Summit Therapeutics· Forrás
Fut, nem toboroz
A Study of Telitacicept for IgA Nephropathy (TELIGAN)
NCT05799287· 3. fázis· RemeGen Co., Ltd.· Forrás
Fut, nem toboroz
The Branch-based Intraoperative Stent System in the Treatment of Stanford A Aortic Dissection(BROAD)
NCT05659641· Permed Biomedical Engineering Co., Ltd· Forrás
Toboroz
Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific
NCT05578300· Chinese University of Hong Kong· Forrás
Contact: Fengyuan Che, MD,PhD